Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSX: $TGOD.TO, TSXV: $OGI.V, TSXV: $KHRN.V, CSE: $VIDA.C, CSE: $PUF.C
#Cannabisstock News for Organigram Holdings Inc., Khiron Life Sciences Corp., Phivida Holdings Inc., The Green Organic Dutchman Holdings Ltd. and PUF Ventures Inc.
Delta, Kelowna, BC - October 2, 2018 (Investorideas.com Newswire) https://www.investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSX: $TGOD.TO, TSXV: $OGI.V, TSXV: $KHRN.V, CSE: $VIDA.C, CSE: $PUF.C
Today's podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com Potcast - following Cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today we will be looking at announcements from Organigram Holdings Inc. trading on the TSX-VENTURE as OGI, Khiron Life Sciences Corp. trading on the TSX-VENTURE as KHRN, Phivida Holdings Inc. trading on the CSE as VIDA, The Green Organic Dutchman Holdings Ltd. trading on the TSX as TGOD and PUF Ventures Inc. trading on the CSE as PUF.
Organigram Holdings Inc., the parent company of Organigram Inc., a leading licensed producer of medical marijuana, announced that is has closed the previously-announced private placement investment in Eviana Health Corporation (CSE:EHC).
Organigram along with an institutional strategic investor each participated 50% in a $10 million debenture offering by Eviana.
"Our investment in Eviana represents just the beginning of our international aspirations" said Greg Engel, CEO of Organigram, "but is representative of our approach to work with trusted local partners to both move quickly with boots on the ground and to navigate regional regulatory issues effectively".
Khiron Life Sciences Corp., an integrated medical cannabis company with its core operations in Colombia, announced today that it has signed multi-channel distribution agreements for Kuida®, its first CBD-based skincare brand. These agreements have been secured with Colombia´s most recognized distributors in the cosmeceutical industry.
Alvaro Torres, Khiron Co-founder and Chief Executive Officer stated, "These key channel partnerships enable us to execute our first go-to-market strategy, by entering the $5.6 Billion Colombian skincare market with significant distribution and access to large and established consumer networks."
As part of a robust strategy, Kuida® launches with secured distributor agreements that leverage their market reach, geographic location, scale and ability to ensure the Kuida® brand achieves its market potential. These agreements reflect retail, on-line and wholesale distribution, and further the strategic goals of the Company's wellness unit.
Retail distribution: Kuida has entered into an exclusive agreement with Farmatodo, one of Colombia´s largest pharmacy chains with 56 stores and over 1.2 Million monthly transactions, generating annual revenue of more than US $120 Million across more than 10 product categories including, medicine, personal care, beauty and skin care, and food and beverage, among others.
The exclusive agreement gives consumers direct product access based on agreed prominent store merchandising and point of purchase display across all Farmatodo stores. Following an exclusive period with Farmatodo, Kuida will also be available at other leading retail chains across the country.
Online Distribution: Kuida has signed an agreement with Farmalisto, Colombia's leading digital drugstore with more than 800,000 monthly visits, sustained annual sales growth of 150% and a strong presence in both Colombia and Mexico. Farmalisto is a leading e-commerce platform, based on a strong CRM program allowing patients and consumers to access medicines and products with ease.
Wholesale Distribution: Kuida has entered into an agreement with Distribuciones AXA S.A., one of Colombia's largest national distributors in the pharmaceutical sector, with 14.000 product SKU's and more than 8,000 retail clients. AXA will play an important role in Kuida´s development, allowing the brand to reach an expanded network of retailers and clients.
Furthermore, Khiron's wellness unit has a robust e-commerce strategy for Kuida that includes direct sales through www.kuidaskincare.com
Phivida Holdings Inc. recently saw the decision by the U.S. Drug Enforcement Administration (DEA) to remove the cannabis component cannabidiol (CBD) from its Schedule 1 list of controlled substances. The DEA defines Schedule 1 as a list of controlled substances with no currently accepted medical use and a high potential for abuse. CBD, when contained in "finished dosage formulations" has now been moved to Schedule 5, defined as drugs with lower potential for abuse. The ruling does not broadly apply to CBD.
"We see this reclassification of CBD in pharmaceuticals as a good sign that will bolster the growing awareness of CBD as a substance that delivers many benefits, and opens the door for other CBD-based treatments, in line with the recent FDA approval of a drug to treat childhood epilepsy," said Jim Bailey, President and CEO. "Phivida is launching its Oki line of functional beverages which provide a spectrum of non-psychoactive phytocannabinoids through infusion with active hemp extract. While our Oki and Vida+ product lines are not subject to FDA approval, as we grow to have product on shelves in all 50 states, we will benefit from the increased acceptance of the efficacy of cannabis and hemp products.
On September 12, 2018, Phivida announced the bottling and launch of its Oki brand of functional beverages and supplements, infused with active hemp extract. Oki will be available to consumers in up to 2,400 natural specialty store locations within the United States, in a significant distribution channel market valued at over USD 4.1 billion in retail sales.
Phivida also announced today the issuance of 1,508,512 common shares of Phivida Holdings. The common shares are for payment for a combination of consulting services provided in regards to an advisory on the Cannabis Beverages Inc. ("CanBev") joint venture with WeedMD Inc. and management sourcing.
The Green Organic Dutchman Holdings Ltd. announced the closing of the previously announced acquisition of HemPoland. The transaction has received approval from the Toronto Stock Exchange and cements the Company's commitment to building shareholder value through international expansion.
"HemPoland has proven an ability to execute through quality product development and strong brand awareness. We are incredibly pleased with this transaction, a key milestone in our long-term acquisitions strategy. The acquisition is accretive to our shareholders, delivers immediate revenue, and opens a new vertical for TGOD. We're incredibly excited to have such an innovative and strong entrepreneurial team join our TGOD family," said Brian Athaide, TGOD's CEO.
Europe is home to three-quarters of a billion potential consumers, and HemPoland is a leading manufacturer and marketer of premium CBD oils within this market. This acquisition provides TGOD with immediate revenue, access to HemPoland's significant distribution network, state-of-the-art hemp oil extraction technology and the premium top selling Cannabigold brand.
PUF Ventures Inc., an advanced ACMPR license applicant,announced that Natures Hemp Corp., a biotechnology and consumer products company focused on unlocking the true value of hemp for both B2B and B2C markets, has reported the successful formulation and initial test results of a hemp based coffee creamer by the Richardson Centre of Functional Foods and Nutraceuticals at the University of Manitoba.
"Working with the University of Manitoba, Natures Hemp formulated an all-natural, hemp-based, non-dairy coffee creamer which tastes good and has all the characteristics of conventional creamers without the worrying ingredients," said Derek Ivany, President and CEO of PUF Ventures. "Coffee drinkers are looking for a healthy alternative to conventional coffee creamers and Natures Hemp all-natural coffee creamer comes with all the healthy benefits of cannabidiols including: healthy omega-3 and omega-6 fatty acids, iron, vitamin E, and essential amino acids."
Hemp is traditionally known for its use in textiles due its long and strong fibers, but hemp seeds have become the source of a robust health food and alternative medicinal marketplace. Hemp seeds are being recognized as a superfood, like flax and chia seeds, because they are high in protein, contain 20 amino acids, and are also high in the fatty acids omega-3 and omega-6. Seeds are typically pressed to produce oil and the remaining byproduct is processed into a flour from which products like pasta, baked goods and other healthy foods can be created. Nature Hemp's healthy alternative non-dairy coffee creamer is made using the whole seed with added water.
If you would like to be a guest or sponsor this podcast contact Investorideas.com
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column and the Cleantech and Climate Change Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Follow us on Social Media
Contact Investorideas.com
800-665-0411
